40‐Year‐old man with two asynchronous spinal cord tumors.

A 40-year-old man presented with two asynchronous spinal cord tumors, diagnosed as spinal ependymoma and myxopapillary ependymoma. The tumors were histologically distinct, requiring molecular analysis for accurate diagnosis. Surgical intervention was crucial for treatment, highlighting the importance of molecular diagnostics in guiding therapeutic decisions for rare CNS tumors. The case study underscores the need for continuous evaluation of treatment options for such tumors. [Extracted from the article]